Empagliflozin Use among Patients with Heart Failure in the Outpatient Department of Medicine in a Tertiary Care Centre

INTRODUCTION: Sodium-glucose co-transporter 2 inhibitors were initially used in the treatment of type 2 diabetes mellitus and subsequently, it was shown to be useful in heart failure among patients with or without diabetes mellitus. This study aimed to find out the prevalence of empagliflozin use am...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghimire, Rinku, Pokharel, Sinet, Jayshwal, Raju, Shreewastav, Rupesh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of the Nepal Medical Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579760/
http://dx.doi.org/10.31729/jnma.8288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579760/
http://dx.doi.org/10.31729/jnma.8288

Ejemplares similares